I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 35% ± 6% | |
| glutamatergic neuron | 3 studies | 44% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 35% ± 6% | |
| glutamatergic neuron | 3 studies | 44% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 890.48 | 1445 / 1445 | 100% | 19.26 | 183 / 183 |
| lung | 100% | 974.39 | 578 / 578 | 100% | 16.76 | 1153 / 1155 |
| intestine | 100% | 918.14 | 966 / 966 | 100% | 14.55 | 525 / 527 |
| ovary | 100% | 1001.12 | 180 / 180 | 100% | 12.04 | 428 / 430 |
| stomach | 100% | 808.75 | 359 / 359 | 99% | 14.91 | 284 / 286 |
| breast | 100% | 967.18 | 459 / 459 | 98% | 16.60 | 1100 / 1118 |
| pancreas | 100% | 838.96 | 328 / 328 | 97% | 10.09 | 173 / 178 |
| bladder | 100% | 921.43 | 21 / 21 | 97% | 12.71 | 489 / 504 |
| prostate | 100% | 949.72 | 245 / 245 | 96% | 12.51 | 484 / 502 |
| brain | 96% | 619.30 | 2549 / 2642 | 99% | 14.99 | 699 / 705 |
| uterus | 100% | 1029.55 | 170 / 170 | 95% | 10.92 | 438 / 459 |
| skin | 100% | 1299.37 | 1809 / 1809 | 95% | 17.77 | 450 / 472 |
| thymus | 100% | 901.42 | 653 / 653 | 95% | 9.44 | 575 / 605 |
| kidney | 100% | 654.29 | 89 / 89 | 95% | 12.48 | 855 / 901 |
| adrenal gland | 100% | 800.25 | 258 / 258 | 91% | 8.58 | 209 / 230 |
| liver | 100% | 591.68 | 226 / 226 | 85% | 7.10 | 344 / 406 |
| adipose | 100% | 965.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1074.72 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1107.16 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 793.46 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 604.87 | 835 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 12.23 | 43 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 14.28 | 27 / 29 |
| peripheral blood | 76% | 523.27 | 702 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 64% | 5.30 | 51 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0060628 | Biological process | regulation of ER to Golgi vesicle-mediated transport |
| GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
| GO_0015031 | Biological process | protein transport |
| GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO_0006890 | Biological process | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0070939 | Cellular component | Dsl1/NZR complex |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RINT1 |
| Protein name | RAD50 interactor 1 RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1) |
| Synonyms | |
| Description | FUNCTION: Involved in regulation of membrane traffic between the Golgi and the endoplasmic reticulum (ER); the function is proposed to depend on its association in the NRZ complex which is believed to play a role in SNARE assembly at the ER. May play a role in cell cycle checkpoint control . Essential for telomere length control . . |
| Accessions | ENST00000257700.7 ENST00000497979.5 C9J5S3 ENST00000467392.5 ENST00000482041.5 F8WC46 F8WAZ2 ENST00000493041.5 F8WDC5 Q6NUQ1 |
